肥胖对乳腺癌发展的影响与更年期状态相关 (综述)
1First Clinical Medical College, Shandong Traditional Chinese Medicine University, Jinan, Shandong 250355, P.R. China.
Molecular and clinical oncology
|March 2, 2026
概括
肥胖是乳腺癌 (BC) 的风险因素,但其影响在绝经前和绝经后的妇女之间有所不同. 需要根据更年期状态分层进行进一步的研究,以了解肥胖症.
科学领域:
- 在瘤学瘤学.
- 流行病学 流行病学
- 内分泌学 在内分泌学.
背景情况:
- 乳腺癌 (BC) 是全球女性的主要癌症.
- 肥胖是一个已确定的BC发展和进展的风险因素.
- 关于肥胖与BC发病率的联系存在不一致的发现,原因是复杂的机制和更年期前和更年期后妇女之间的差异.
研究的目的:
- 调查肥胖对乳腺癌发病率的具体影响.
- 通过基于更年期状态的分层分析来解决当前流行病学研究中的不一致性.
- 为乳腺癌的有针对性的预防策略提供信息.
主要方法:
- 流行病学分析.流行病学分析.
- 根据更年期状态对数据进行分层划分 (更年期前与更年期后).
- 检查肥胖与乳腺癌发病率的关联.
主要成果:
- 之前的研究中不一致的结果凸显了分层分析的必要性.
- 更年期状态显著影响肥胖和乳腺癌之间的关系.
结论:
- 根据更年期状况对乳腺癌研究进行分层研究对于了解肥胖的作用至关重要.
- 为了制定有效的,有针对性的乳腺癌预防策略,需要有差异化的见解.
相关概念视频
Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
326
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
326
Drug Dosing: Obese Patients
316
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
316
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
250
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
250
Psychoneuroimmunology: Diabetes and Cancer
549
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
549
Menopause
5.1K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.1K


